Literature DB >> 17220753

A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol.

Chantal P Bleeker-Rovers1, Fidel J Vos, Elisabeth M H A de Kleijn, Aart H Mudde, Ton S M Dofferhoff, Clemens Richter, Tineke J Smilde, Paul F M Krabbe, Wim J G Oyen, Jos W M van der Meer.   

Abstract

We conducted a prospective study to update our knowledge of fever of unknown origin (FUO) and to explore the utility of a structured diagnostic protocol. From December 2003 to July 2005, 73 patients with FUO were recruited from 1 university hospital (n = 40) and 5 community hospitals (n = 33) in the same region in The Netherlands. FUO was defined as a febrile illness of >3 weeks' duration, a temperature of >38.3 degrees C on several occasions, without a diagnosis after standardized history-taking, physical examination, and certain obligatory investigations. Immunocompromised patients were excluded. A structured diagnostic protocol was used. Patients from the university hospital were characterized by more secondary referrals and a higher percentage of periodic fever than those referred to community hospitals. Infection was the cause in 16%, a neoplasm in 7%, noninfectious inflammatory diseases in 22%, miscellaneous causes in 4%, and in 51%, the cause of fever was not found (no differences between university and community hospitals). There were no differences regarding the number and type of investigations between university and community hospitals. Significant predictors for reaching a diagnosis included continuous fever; fever present for <180 days; elevated erythrocyte sedimentation rate, C-reactive protein, or lactate dehydrogenase; leukopenia; thrombocytosis; abnormal chest computed tomography (CT); and abnormal F-fluorodeoxyglucose positron emission tomography (FDG-PET). For future FUO studies, inclusion of outpatients and the use of a set of obligated investigations instead of a time-related criterion are recommended. Except for tests from the obligatory part of our protocol and cryoglobulins in an early stage, followed by FDG-PET, and in a later stage by abdominal and chest CT, temporal artery biopsy in patients aged 55 years or older, and possibly bone marrow biopsy, other tests should not be used as screening investigations.

Entities:  

Mesh:

Year:  2007        PMID: 17220753     DOI: 10.1097/MD.0b013e31802fe858

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  74 in total

Review 1.  Fever in Children and Fever of Unknown Origin.

Authors:  Rajeshwar Dayal; Dipti Agarwal
Journal:  Indian J Pediatr       Date:  2015-03-01       Impact factor: 1.967

2.  Establishment of a Predictive Model Related to Pathogen Invasion for Infectious Diseases and Its Diagnostic Value in Fever of Unknown Origin.

Authors:  Zhu-Hua Wu; Ming-You Xing; Sheng Wei; Man-Zhi Zhao; Wen-Xia Wang; Lin Zhu; Ji-Ling Zhu; Cai-Feng Zheng; Si-Jun Wang; Jun-Ying Qi; Jian-Xin Song
Journal:  Curr Med Sci       Date:  2018-12-07

3.  Giant cell arteritis presenting as isolated inflammatory response and/or fever of unknown origin: a case-control study.

Authors:  Hubert de Boysson; Eric Liozon; Kim Heang Ly; Anael Dumont; Claire Delmas; Audrey Sultan; Achille Aouba
Journal:  Clin Rheumatol       Date:  2018-07-30       Impact factor: 2.980

4.  Fever of unknown origin: a retrospective review of pediatric patients from an urban, tertiary care center in Washington, DC.

Authors:  Ann Marie Szymanski; Hugo Clifford; Tova Ronis
Journal:  World J Pediatr       Date:  2019-03-19       Impact factor: 2.764

5.  Left pleural effusion and fever of unknown origin--a clue to thoracic arterial pathology.

Authors:  Ami Schattner; Abraham Klepfish
Journal:  J Gen Intern Med       Date:  2012-02-24       Impact factor: 5.128

6.  F-18 FDG-PET/CT in evaluation of patients with fever of unknown origin.

Authors:  Kuruva Manohar; Bhagwant Rai Mittal; Sanjay Jain; Aman Sharma; Naveen Kalra; Anish Bhattacharya; Subhash Varma
Journal:  Jpn J Radiol       Date:  2013-03-01       Impact factor: 2.374

7.  Guidelines for the use of 18F-FDG in infection and inflammation: a new step in cooperation between the EANM and SNMMI.

Authors:  J Buscombe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07       Impact factor: 9.236

Review 8.  Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection.

Authors:  Wei Gu; Steve Miller; Charles Y Chiu
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

Review 9.  Recent trends in soft-tissue infection imaging.

Authors:  Nicholas Petruzzi; Nylla Shanthly; Mathew Thakur
Journal:  Semin Nucl Med       Date:  2009-03       Impact factor: 4.446

10.  Fever of unknown origin: 98 cases from Saudi Arabia.

Authors:  Mahmoud A Moawad; Habib Bassil; Mona Elsherif; Abeer Ibrahim; Moustafa Elnaggar; Jameela Edathodu; Abdulaziz Alharthi; Muneerah Albugami; Ahmed Sabry; Mohammed Shoukri; Ibtisam Bakhsh; Ulrike Laudon
Journal:  Ann Saudi Med       Date:  2010 Jul-Aug       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.